Anlongmed Fund
10
4M
10
2
1
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Connect Biopharmaceuticals, Laekna Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Anlongmed Fund, startups are often financed by C-Bridge Capital. The meaningful sponsors for the fund in investment in the same round are XinYue Equity, OrbiMed, Cowin Capital. In the next rounds fund is usually obtained by Qiming Venture Partners, Northern Light Venture Capital, Cowin Capital.
The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 2
- Exits
- 1
- Investments by industry
- Health Care (7)
- Medical (5)
- Biotechnology (4)
- Medical Device (1)
- Clinical Trials (1) Show 2 more
- Investments by region
-
- China (10)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Qianglian Zhichuang | 01 Jan 2017 | Medical | Seed | Beijing, Beijing, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.